Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001513162-23-000057
Filing Date
2023-04-10
Accepted
2023-04-10 14:43:18
Documents
1
Period of Report
2023-04-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3924
  Complete submission text file 0001513162-23-000057.txt   5524
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Issuer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 12136 AHERN CT TUSTIN CA 92782
Business Address
Lu Gary (Reporting) CIK: 0001968621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37863 | Film No.: 23810812